Susan M. Rowe

The Use of α-Aminoboronic Acid Derivatives to Stabilize Peptide Drugs During Their Intranasal Absorption

Munir Hussain, Ashok B. Shenvi, Susan M. Rowe et al. · Pharmaceutical Research · 1989 · 56 citations

Amphiphilic vehicles improve the oral bioavailability of a poorly soluble HIV protease inhibitor at high doses1Portions of this work were presented at Journeé Galéniques de Saint-Rémy de Provence, May 1994, and at the AAPS Eastern Regional Meeting, June 1994.1

Bruce J. Aungst, Nhung H. A. Nguyen, Nancy J. Rogers et al. · International Journal of Pharmaceutics · 1997 · 46 citations

Medicinal Chemistry, Oral Bioavailability, June 1994.1 +10

Kinetics and Mechanism of Hydrolysis of Efavirenz

Michael B. Maurin, Susan M. Rowe, Karl F. Blom et al. · Pharmaceutical Research · 2002 · 38 citations

Nasal administration of a cognition enhancer provides improved bioavailability but not enhanced brain delivery

Munir Hussain, Dariel C. Rakestraw, Susan M. Rowe et al. · Journal of Pharmaceutical Sciences · 1990 · 35 citations

Cognitive Science, Cognitive Performance, Brain Function +11

Determination of the pK_aand pH-Solubility Behavior of an Ionizable Cyclic Carbamate, (S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one (DMP 266)

Shelley R. Rabel, Michael B. Maurin, Susan M. Rowe et al. · Pharmaceutical Development and Technology · 1996 · 26 citations

Bioorganic Chemistry, Organic Chemistry, Chemistry +20